Literature DB >> 8970585

A review of inherited predisposition to melanoma.

L A Cannon-Albright1, A Kamb, M Skolnick.   

Abstract

In this review, we discuss the progress of the last few years in the genetic analysis of the susceptibility to melanoma. The inclusion of dysplastic nevi in the analysis of susceptibility, although appropriate conceptually, has not greatly clarified the picture of genetic susceptibility to melanoma. One predisposing gene has clearly been linked to chromosome 9 while a second linkage to chromosome 1 is still uncertain. A gene, CDKN2, is an appealing candidate for melanoma susceptibility.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8970585

Source DB:  PubMed          Journal:  Semin Oncol        ISSN: 0093-7754            Impact factor:   4.929


  4 in total

Review 1.  Familial aggregation of glioma: a pooled analysis.

Authors:  Michael E Scheurer; Carol J Etzel; Mei Liu; Jill Barnholtz-Sloan; Fredrik Wiklund; Björn Tavelin; Margaret R Wrensch; Beatrice S Melin; Melissa L Bondy
Journal:  Am J Epidemiol       Date:  2010-09-21       Impact factor: 4.897

2.  Aggregation of cancer in first-degree relatives of patients with glioma.

Authors:  Michael E Scheurer; Carol J Etzel; Mei Liu; Randa El-Zein; Gladstone E Airewele; Beatrice Malmer; Kenneth D Aldape; Jeffrey S Weinberg; W K Alfred Yung; Melissa L Bondy
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2007-11       Impact factor: 4.254

3.  Notch1 is an effector of Akt and hypoxia in melanoma development.

Authors:  Barbara Bedogni; James A Warneke; Brian J Nickoloff; Amato J Giaccia; Marianne Broome Powell
Journal:  J Clin Invest       Date:  2008-10-16       Impact factor: 14.808

4.  Germline rearrangements in families with strong family history of glioma and malignant melanoma, colon, and breast cancer.

Authors:  Ulrika Andersson; Carl Wibom; Kristina Cederquist; Steina Aradottir; Ake Borg; Georgina N Armstrong; Sanjay Shete; Ching C Lau; Matthew N Bainbridge; Elizabeth B Claus; Jill Barnholtz-Sloan; Rose Lai; Dora Il'yasova; Richard S Houlston; Joellen Schildkraut; Jonine L Bernstein; Sara H Olson; Robert B Jenkins; Daniel H Lachance; Margaret Wrensch; Faith G Davis; Ryan Merrell; Christoffer Johansen; Siegal Sadetzki; Melissa L Bondy; Beatrice S Melin
Journal:  Neuro Oncol       Date:  2014-04-09       Impact factor: 12.300

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.